Read twice and referred to the Committee on the Judiciary.
The Don’t Sell My DNA Act amends the Bankruptcy Code to treat genetic information specially. It bars approval of any sale, use, or lease of genetic information from a bankruptcy estate unless every affected person affirmatively consents in writing after the case starts, requires actual prior written notice to affected persons, and requires trustees to securely delete estate genetic information not sold or otherwise disposed of.
Privacy protection versus bankruptcy asset monetization and creditor recovery
Relative to its intended legislative type, this bill is a focused substantive amendment to the Bankruptcy Code that establishes protections for genetic information by prohibiting sale/use/lease without affirmative written consent, requiring prior written notice to affected persons, and mandating deletion of non‑disposed genetic data using court‑prescribed methods.
The Don’t Sell My DNA Act amends the Bankruptcy Code to treat genetic information specially.
It bars approval of any sale, use, or lease of genetic information from a bankruptcy estate unless every affected person affirmatively consents in writing after the case starts, requires actual prior written notice to affected persons, and requires trustees to securely delete estate genetic information not sold or otherwise disposed of.
The changes take effect on enactment and apply to pending and future cases.
Technocratic privacy measure with limited costs improves chances, but stakeholder pushback and committee/filibuster realities leave moderate uncertainty.
Relative to its intended legislative type, this bill is a focused substantive amendment to the Bankruptcy Code that establishes protections for genetic information by prohibiting sale/use/lease without affirmative written consent, requiring prior written notice to affected persons, and mandating deletion of non‑disposed genetic data using court‑prescribed methods.
Privacy protection versus bankruptcy asset monetization and creditor recovery
These are examples from the analysis, not a ranked list of the most-affected groups.
Privacy protection versus bankruptcy asset monetization and creditor recovery
Seen as a needed privacy protection preventing monetization of sensitive genetic data through bankruptcy.
It closes a gap that could expose non-debtors and relatives to commercial exploitation of DNA.
Views the bill as a reasonable targeted privacy measure but worries about procedural friction in bankruptcy.
Supports protections but wants clarity on costs, court mechanics, and narrowness of scope.
Sees the bill as a federal intrusion into bankruptcy asset administration that restricts property monetization.
Concerns center on creditor recoveries, added costs, and precedent for restricting sales of estate assets.
Reached or meaningfully advanced
Reached or meaningfully advanced
Still ahead
Still ahead
Still ahead
Technocratic privacy measure with limited costs improves chances, but stakeholder pushback and committee/filibuster realities leave moderate uncertainty.
The bill has not accumulated any surfaced votes yet.
Privacy protection versus bankruptcy asset monetization and creditor recovery
Technocratic privacy measure with limited costs improves chances, but stakeholder pushback and committee/filibuster realities leave moderat…
Relative to its intended legislative type, this bill is a focused substantive amendment to the Bankruptcy Code that establishes protections for genetic information by prohibiting sale/use/lease without affirmative writt…
Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.